Publications by authors named "Maria Wagnerova"

Claim this Profile
T
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.
Michal Mego, Barbora Kasperova, Jozef Chovanec, Radoslav Danis, Maria Reckova, Maria Wagnerova

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12 LGG in colorectal cancer patients.
Michal Mego, Radoslav Danis, Jozef Chovanec, Silvia Jurisova, Branislav Bystricky, Maria Wagnerova

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy.
Alíz Nikolényi, Gabriella Uhercsák, Melinda Csenki, Sándor Hamar, Erika Csörgo, Maria Wagnerova

Pathol Oncol Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.
Wim W Ten Bokkel Huinink, Jozef Sufliarsky, Willem M Smit, Stanislav Spanik, Maria Wagnerova

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).
Zsuzsanna Kahán, Stanislav Spanik, Maria Wagnerova, Tomas Skacel, Barbara Planko

Breast Cancer Res Treat· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
Thomas Brodowicz, Maciej Krzakowski, Matjaz Zwitter, Valentina Tzekova, Rodryg Ramlau, Maria Wagnerova

Lung Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.
Christoph Zielinski, Semir Beslija, Zrinka Mrsic-Krmpotic, Marzena Welnicka-Jaskiewicz, Christoph Wiltschke, Maria Wagnerova

J Clin Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis